Deep-pocketed investors have adopted a bullish approach towards Moderna MRNA, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MRNA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Moderna. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 53% leaning bullish and 30% bearish. Among these notable options, 7 are puts, totaling $297,350, and 6 are calls, amounting to $438,406.
Projected Price Targets
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $210.0 for Moderna over the last 3 months.
Insights into Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale trades within a strike price range from $100.0 to $210.0 in the last 30 days.
Moderna Option Activity Analysis: Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | CALL | SWEEP | BULLISH | 09/20/24 | $8.3 | $8.05 | $8.2 | $140.00 | $205.0K | 299 | 1 |
| MRNA | CALL | SWEEP | BULLISH | 06/21/24 | $4.35 | $4.15 | $4.28 | $130.00 | $97.8K | 3.4K | 56 |
| MRNA | PUT | SWEEP | BULLISH | 06/21/24 | $6.9 | $6.7 | $6.7 | $120.00 | $69.6K | 534 | 1.2K |
| MRNA | PUT | SWEEP | BULLISH | 06/21/24 | $6.8 | $6.75 | $6.8 | $120.00 | $55.0K | 534 | 185 |
| MRNA | PUT | SWEEP | BEARISH | 06/21/24 | $6.7 | $6.6 | $6.7 | $120.00 | $46.9K | 534 | 416 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Having examined the options trading patterns of Moderna, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Present Market Standing of Moderna
- Trading volume stands at 914,961, with MRNA's price down by -3.4%, positioned at $120.75.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 87 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
